Clinical trial
A Phase 3, Open-label, Randomized, Multi-center, Controlled Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of Edoxaban and to Compare the Efficacy and Safety of Edoxaban With Standard of Care Anticoagulant Therapy in Pediatric Subjects From Birth to Less Than 18 Years of Age With Confirmed Venous Thromboembolism (VTE)
NCT02798471 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Open-label, Randomized, Multi-center, Controlled Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of Edoxaban and to Compare the Efficacy and Safety of Edoxaban With Standard of Care Anticoagulant Therapy in Pediatric Subjects From Birth to Less Than 18 Years of Age With Confirmed Venous Thromboembolism (VTE)
- Lead sponsor
- Daiichi Sankyo
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 27, 2017
- Completion date
- May 24, 2022
- Enrollment
- 290 (actual)
- Sites
- 140
Conditions
As the registry lists them; a condition with its own page is linked.
deep vein thrombosis (dvt), pulmonary embolism, venous thromboembolism (vte)